nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—NR3C1—polycystic ovary syndrome	0.866	1	CbGaD
Flunisolide—Sinus congestion—Metformin—polycystic ovary syndrome	0.00632	0.0725	CcSEcCtD
Flunisolide—Upset stomach—Metformin—polycystic ovary syndrome	0.0048	0.055	CcSEcCtD
Flunisolide—Heartburn—Metformin—polycystic ovary syndrome	0.00457	0.0524	CcSEcCtD
Flunisolide—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00388	0.0445	CcSEcCtD
Flunisolide—NR3C1—urine—polycystic ovary syndrome	0.00369	0.186	CbGeAlD
Flunisolide—Chest discomfort—Metformin—polycystic ovary syndrome	0.00355	0.0408	CcSEcCtD
Flunisolide—Accidental injury—Metformin—polycystic ovary syndrome	0.00355	0.0408	CcSEcCtD
Flunisolide—CYP3A4—urine—polycystic ovary syndrome	0.00279	0.141	CbGeAlD
Flunisolide—Ear pain—Metformin—polycystic ovary syndrome	0.00268	0.0307	CcSEcCtD
Flunisolide—Nasal congestion—Metformin—polycystic ovary syndrome	0.00251	0.0287	CcSEcCtD
Flunisolide—Injury—Metformin—polycystic ovary syndrome	0.00248	0.0285	CcSEcCtD
Flunisolide—Migraine—Metformin—polycystic ovary syndrome	0.00225	0.0258	CcSEcCtD
Flunisolide—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00204	0.0234	CcSEcCtD
Flunisolide—Abdominal distension—Metformin—polycystic ovary syndrome	0.00199	0.0228	CcSEcCtD
Flunisolide—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00189	0.0217	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00183	0.021	CcSEcCtD
Flunisolide—SERPINA6—pituitary gland—polycystic ovary syndrome	0.0018	0.091	CbGeAlD
Flunisolide—SERPINA6—adrenal gland—polycystic ovary syndrome	0.00161	0.0813	CbGeAlD
Flunisolide—Rhinitis—Metformin—polycystic ovary syndrome	0.00158	0.0182	CcSEcCtD
Flunisolide—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00157	0.018	CcSEcCtD
Flunisolide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00156	0.0178	CcSEcCtD
Flunisolide—Chills—Metformin—polycystic ovary syndrome	0.00142	0.0163	CcSEcCtD
Flunisolide—SERPINA6—endocrine gland—polycystic ovary syndrome	0.0014	0.0705	CbGeAlD
Flunisolide—Malnutrition—Metformin—polycystic ovary syndrome	0.00137	0.0158	CcSEcCtD
Flunisolide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00135	0.0154	CcSEcCtD
Flunisolide—Vision blurred—Metformin—polycystic ovary syndrome	0.0013	0.0149	CcSEcCtD
Flunisolide—Tremor—Metformin—polycystic ovary syndrome	0.00129	0.0148	CcSEcCtD
Flunisolide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00128	0.0146	CcSEcCtD
Flunisolide—Malaise—Metformin—polycystic ovary syndrome	0.00124	0.0142	CcSEcCtD
Flunisolide—Syncope—Metformin—polycystic ovary syndrome	0.00123	0.0141	CcSEcCtD
Flunisolide—Palpitations—Metformin—polycystic ovary syndrome	0.00121	0.0139	CcSEcCtD
Flunisolide—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00121	0.0139	CcSEcCtD
Flunisolide—NR3C1—embryo—polycystic ovary syndrome	0.00119	0.0602	CbGeAlD
Flunisolide—Hypertension—Metformin—polycystic ovary syndrome	0.00119	0.0136	CcSEcCtD
Flunisolide—Chest pain—Metformin—polycystic ovary syndrome	0.00117	0.0134	CcSEcCtD
Flunisolide—Myalgia—Metformin—polycystic ovary syndrome	0.00117	0.0134	CcSEcCtD
Flunisolide—Discomfort—Metformin—polycystic ovary syndrome	0.00116	0.0133	CcSEcCtD
Flunisolide—Oedema—Metformin—polycystic ovary syndrome	0.00112	0.0129	CcSEcCtD
Flunisolide—Infection—Metformin—polycystic ovary syndrome	0.00111	0.0128	CcSEcCtD
Flunisolide—Shock—Metformin—polycystic ovary syndrome	0.0011	0.0127	CcSEcCtD
Flunisolide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00108	0.0124	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00102	0.0117	CcSEcCtD
Flunisolide—Dyspnoea—Metformin—polycystic ovary syndrome	0.001	0.0115	CcSEcCtD
Flunisolide—Dyspepsia—Metformin—polycystic ovary syndrome	0.000987	0.0113	CcSEcCtD
Flunisolide—NR3C1—adrenal cortex—polycystic ovary syndrome	0.000977	0.0493	CbGeAlD
Flunisolide—Decreased appetite—Metformin—polycystic ovary syndrome	0.000975	0.0112	CcSEcCtD
Flunisolide—Fatigue—Metformin—polycystic ovary syndrome	0.000967	0.0111	CcSEcCtD
Flunisolide—Constipation—Metformin—polycystic ovary syndrome	0.000959	0.011	CcSEcCtD
Flunisolide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000924	0.0106	CcSEcCtD
Flunisolide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000917	0.0105	CcSEcCtD
Flunisolide—Urticaria—Metformin—polycystic ovary syndrome	0.000891	0.0102	CcSEcCtD
Flunisolide—Abdominal pain—Metformin—polycystic ovary syndrome	0.000887	0.0102	CcSEcCtD
Flunisolide—NR3C1—endometrium—polycystic ovary syndrome	0.000873	0.0441	CbGeAlD
Flunisolide—Asthenia—Metformin—polycystic ovary syndrome	0.000805	0.00923	CcSEcCtD
Flunisolide—NR3C1—uterus—polycystic ovary syndrome	0.000804	0.0406	CbGeAlD
Flunisolide—Pruritus—Metformin—polycystic ovary syndrome	0.000794	0.0091	CcSEcCtD
Flunisolide—NR3C1—pituitary gland—polycystic ovary syndrome	0.00079	0.0399	CbGeAlD
Flunisolide—NR3C1—adipose tissue—polycystic ovary syndrome	0.000786	0.0397	CbGeAlD
Flunisolide—Diarrhoea—Metformin—polycystic ovary syndrome	0.000768	0.0088	CcSEcCtD
Flunisolide—Dizziness—Metformin—polycystic ovary syndrome	0.000742	0.00851	CcSEcCtD
Flunisolide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.000722	0.048	CbGpPWpGaD
Flunisolide—Vomiting—Metformin—polycystic ovary syndrome	0.000713	0.00818	CcSEcCtD
Flunisolide—Rash—Metformin—polycystic ovary syndrome	0.000707	0.00811	CcSEcCtD
Flunisolide—Dermatitis—Metformin—polycystic ovary syndrome	0.000707	0.00811	CcSEcCtD
Flunisolide—NR3C1—adrenal gland—polycystic ovary syndrome	0.000705	0.0356	CbGeAlD
Flunisolide—Headache—Metformin—polycystic ovary syndrome	0.000703	0.00806	CcSEcCtD
Flunisolide—Nausea—Metformin—polycystic ovary syndrome	0.000666	0.00764	CcSEcCtD
Flunisolide—NR3C1—female gonad—polycystic ovary syndrome	0.000658	0.0332	CbGeAlD
Flunisolide—NR3C1—vagina—polycystic ovary syndrome	0.000654	0.033	CbGeAlD
Flunisolide—NR3C1—endocrine gland—polycystic ovary syndrome	0.000612	0.0309	CbGeAlD
Flunisolide—Difluprednate—NR3C1—polycystic ovary syndrome	0.000514	0.0429	CrCbGaD
Flunisolide—Prednicarbate—NR3C1—polycystic ovary syndrome	0.000499	0.0416	CrCbGaD
Flunisolide—Clocortolone—NR3C1—polycystic ovary syndrome	0.000499	0.0416	CrCbGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—INSR—polycystic ovary syndrome	0.000481	0.032	CbGpPWpGaD
Flunisolide—Diflorasone—NR3C1—polycystic ovary syndrome	0.000472	0.0393	CrCbGaD
Flunisolide—Desonide—NR3C1—polycystic ovary syndrome	0.000472	0.0393	CrCbGaD
Flunisolide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000463	0.0234	CbGeAlD
Flunisolide—Desoximetasone—NR3C1—polycystic ovary syndrome	0.00046	0.0383	CrCbGaD
Flunisolide—Loteprednol—NR3C1—polycystic ovary syndrome	0.000455	0.0379	CrCbGaD
Flunisolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—polycystic ovary syndrome	0.000444	0.0295	CbGpPWpGaD
Flunisolide—Flurandrenolide—NR3C1—polycystic ovary syndrome	0.000403	0.0336	CrCbGaD
Flunisolide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.000402	0.0267	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000401	0.0267	CbGpPWpGaD
Flunisolide—Flumethasone Pivalate—NR3C1—polycystic ovary syndrome	0.000396	0.033	CrCbGaD
Flunisolide—Halobetasol Propionate—NR3C1—polycystic ovary syndrome	0.00039	0.0325	CrCbGaD
Flunisolide—Fluticasone Propionate—PGR—polycystic ovary syndrome	0.000384	0.032	CrCbGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—polycystic ovary syndrome	0.000379	0.0252	CbGpPWpGaD
Flunisolide—Amcinonide—NR3C1—polycystic ovary syndrome	0.000362	0.0302	CrCbGaD
Flunisolide—Budesonide—NR3C1—polycystic ovary syndrome	0.000362	0.0302	CrCbGaD
Flunisolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—polycystic ovary syndrome	0.000357	0.0238	CbGpPWpGaD
Flunisolide—Fluticasone furoate—NR3C1—polycystic ovary syndrome	0.000355	0.0296	CrCbGaD
Flunisolide—Betamethasone—PGR—polycystic ovary syndrome	0.000352	0.0293	CrCbGaD
Flunisolide—Mometasone—NR3C1—polycystic ovary syndrome	0.000345	0.0287	CrCbGaD
Flunisolide—Rimexolone—NR3C1—polycystic ovary syndrome	0.000341	0.0284	CrCbGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—polycystic ovary syndrome	0.000323	0.0215	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.000322	0.0214	CbGpPWpGaD
Flunisolide—Fluocinonide—NR3C1—polycystic ovary syndrome	0.000321	0.0268	CrCbGaD
Flunisolide—Fluocinolone Acetonide—NR3C1—polycystic ovary syndrome	0.000312	0.026	CrCbGaD
Flunisolide—Alclometasone—NR3C1—polycystic ovary syndrome	0.000312	0.026	CrCbGaD
Flunisolide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.000309	0.0206	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—LIFR—polycystic ovary syndrome	0.000303	0.0202	CbGpPWpGaD
Flunisolide—Paramethasone—NR3C1—polycystic ovary syndrome	0.0003	0.025	CrCbGaD
Flunisolide—Ciclesonide—NR3C1—polycystic ovary syndrome	0.000295	0.0246	CrCbGaD
Flunisolide—Fluorometholone—NR3C1—polycystic ovary syndrome	0.000293	0.0244	CrCbGaD
Flunisolide—NR3C1—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000288	0.0191	CbGpPWpGaD
Flunisolide—Methylprednisolone—NR3C1—polycystic ovary syndrome	0.000283	0.0236	CrCbGaD
Flunisolide—Dexamethasone—CYP17A1—polycystic ovary syndrome	0.000276	0.023	CrCbGaD
Flunisolide—Dexamethasone—CYP11A1—polycystic ovary syndrome	0.000272	0.0226	CrCbGaD
Flunisolide—Hydrocortisone—SHBG—polycystic ovary syndrome	0.000257	0.0214	CrCbGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.000256	0.017	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—IRS2—polycystic ovary syndrome	0.000255	0.0169	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—LEP—polycystic ovary syndrome	0.000249	0.0166	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—LIF—polycystic ovary syndrome	0.000247	0.0164	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—RETN—polycystic ovary syndrome	0.000247	0.0164	CbGpPWpGaD
Flunisolide—Betamethasone—CYP19A1—polycystic ovary syndrome	0.000241	0.0201	CrCbGaD
Flunisolide—Triamcinolone—NR3C1—polycystic ovary syndrome	0.000239	0.0199	CrCbGaD
Flunisolide—NR3C1—Circadian Clock—NAMPT—polycystic ovary syndrome	0.000236	0.0157	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000227	0.0151	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptors—AR—polycystic ovary syndrome	0.000224	0.0149	CbGpPWpGaD
Flunisolide—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000222	0.0148	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—IRS1—polycystic ovary syndrome	0.000222	0.0148	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—polycystic ovary syndrome	0.000217	0.0144	CbGpPWpGaD
Flunisolide—Prednisone—NR3C1—polycystic ovary syndrome	0.000217	0.0181	CrCbGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.000216	0.0144	CbGpPWpGaD
Flunisolide—Fluticasone Propionate—NR3C1—polycystic ovary syndrome	0.000214	0.0178	CrCbGaD
Flunisolide—Dexamethasone—PGR—polycystic ovary syndrome	0.000205	0.0171	CrCbGaD
Flunisolide—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.000203	0.0135	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—polycystic ovary syndrome	0.0002	0.0133	CbGpPWpGaD
Flunisolide—Prednisolone—NR3C1—polycystic ovary syndrome	0.0002	0.0166	CrCbGaD
Flunisolide—Betamethasone—NR3C1—polycystic ovary syndrome	0.000196	0.0163	CrCbGaD
Flunisolide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.000194	0.0129	CbGpPWpGaD
Flunisolide—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000188	0.0125	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.000177	0.0118	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000172	0.0114	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000172	0.0114	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—AR—polycystic ovary syndrome	0.000171	0.0114	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TH—polycystic ovary syndrome	0.000154	0.0103	CbGpPWpGaD
Flunisolide—Hydrocortisone—NR3C1—polycystic ovary syndrome	0.000153	0.0127	CrCbGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	0.000153	0.0102	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—NCOR1—polycystic ovary syndrome	0.000146	0.00968	CbGpPWpGaD
Flunisolide—Dexamethasone—CYP19A1—polycystic ovary syndrome	0.00014	0.0117	CrCbGaD
Flunisolide—NR3C1—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.00014	0.00932	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000134	0.00891	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—polycystic ovary syndrome	0.000129	0.00858	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000128	0.00851	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—PRL—polycystic ovary syndrome	0.000126	0.00839	CbGpPWpGaD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000123	0.00815	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.000122	0.00813	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—polycystic ovary syndrome	0.000122	0.00812	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—NAMPT—polycystic ovary syndrome	0.000118	0.00787	CbGpPWpGaD
Flunisolide—Dexamethasone—NR3C1—polycystic ovary syndrome	0.000114	0.00948	CrCbGaD
Flunisolide—NR3C1—Adipogenesis—LMNA—polycystic ovary syndrome	0.000112	0.00746	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000112	0.00742	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000111	0.00737	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000107	0.0071	CbGpPWpGaD
Flunisolide—Dexamethasone—CYP1A1—polycystic ovary syndrome	0.000103	0.00861	CrCbGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—BAX—polycystic ovary syndrome	0.000103	0.00685	CbGpPWpGaD
Flunisolide—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000103	0.00682	CbGpPWpGaD
Flunisolide—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	9.86e-05	0.00656	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—ADIPOQ—polycystic ovary syndrome	9.68e-05	0.00644	CbGpPWpGaD
Flunisolide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	9.48e-05	0.0063	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	9.41e-05	0.00626	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—SERPINE1—polycystic ovary syndrome	9.39e-05	0.00625	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—IL6—polycystic ovary syndrome	9.3e-05	0.00619	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—SLC2A4—polycystic ovary syndrome	9.15e-05	0.00608	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ZNF205—polycystic ovary syndrome	8.27e-05	0.0055	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ZNF430—polycystic ovary syndrome	8.27e-05	0.0055	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	8.13e-05	0.0054	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—POMC—polycystic ovary syndrome	7.47e-05	0.00497	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—NCOR1—polycystic ovary syndrome	7.31e-05	0.00486	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	7.23e-05	0.00481	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	7.18e-05	0.00478	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	7.09e-05	0.00471	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ADARB1—polycystic ovary syndrome	7.03e-05	0.00468	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	6.89e-05	0.00458	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	6.73e-05	0.00447	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	6.68e-05	0.00444	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	6.59e-05	0.00438	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	6.53e-05	0.00435	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IRS2—polycystic ovary syndrome	6.15e-05	0.00409	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—LEP—polycystic ovary syndrome	6.02e-05	0.004	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	5.82e-05	0.00387	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—LSM5—polycystic ovary syndrome	5.73e-05	0.00381	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	5.41e-05	0.0036	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IRS1—polycystic ovary syndrome	5.37e-05	0.00357	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SAP30L—polycystic ovary syndrome	5.33e-05	0.00354	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	5.28e-05	0.00351	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	5.27e-05	0.0035	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—PPARG—polycystic ovary syndrome	5.24e-05	0.00348	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	5.21e-05	0.00347	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—INS—polycystic ovary syndrome	5.14e-05	0.00342	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	5.07e-05	0.00337	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IGF1—polycystic ovary syndrome	4.97e-05	0.00331	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—SERPINE1—polycystic ovary syndrome	4.72e-05	0.00314	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—TEAD2—polycystic ovary syndrome	4.53e-05	0.00301	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	4.5e-05	0.00299	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	4.28e-05	0.00285	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	4.26e-05	0.00283	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	4.2e-05	0.00279	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	3.93e-05	0.00261	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	3.74e-05	0.00249	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	3.68e-05	0.00245	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	3.49e-05	0.00232	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	3.45e-05	0.0023	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	3.44e-05	0.00229	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	3.25e-05	0.00216	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	3.23e-05	0.00215	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	3.18e-05	0.00211	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	3.09e-05	0.00206	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	3.05e-05	0.00203	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	3.05e-05	0.00203	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	2.88e-05	0.00192	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	2.87e-05	0.00191	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	2.84e-05	0.00189	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	2.81e-05	0.00187	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	2.67e-05	0.00178	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	2.57e-05	0.00171	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.27e-05	0.00151	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	2.25e-05	0.00149	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.24e-05	0.00149	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	2.17e-05	0.00144	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	1.94e-05	0.00129	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	1.91e-05	0.00127	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	1.91e-05	0.00127	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	1.89e-05	0.00126	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.83e-05	0.00122	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.81e-05	0.0012	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	1.72e-05	0.00115	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.61e-05	0.00107	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.48e-05	0.000981	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.48e-05	0.000981	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—AR—polycystic ovary syndrome	1.47e-05	0.000978	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.37e-05	0.000912	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.37e-05	0.000909	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	1.29e-05	0.000855	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.17e-05	0.000775	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.17e-05	0.000775	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	9.77e-06	0.00065	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	9.26e-06	0.000616	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	9.21e-06	0.000613	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.84e-06	0.000588	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	8.3e-06	0.000552	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.88e-06	0.000524	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.51e-06	0.0005	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.85e-06	0.000456	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.7e-06	0.000445	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.49e-06	0.000431	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.97e-06	0.000397	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.78e-06	0.000384	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.57e-06	0.000371	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.35e-06	0.000356	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.29e-06	0.000352	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.99e-06	0.000332	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.92e-06	0.000327	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.25e-06	0.000283	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.14e-06	0.000275	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.89e-06	0.000259	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.47e-06	0.000231	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.31e-06	0.00022	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.14e-06	0.000209	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.92e-06	0.000194	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.37e-06	0.000158	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.34e-06	0.000155	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.33e-06	0.000155	CbGpPWpGaD
